Court: United States District Court for the Northern District of Illinois
Case No.: MDL No. 1182
Filed originally by Ken Wexler’s previous firm, this case was successfully prosecuted on behalf of consumers of the pharmaceutical Synthroid against its brand name manufacturer. The Synthroid case was one of the first, if not the first, cases brought against a brand name pharmaceutical manufacturer for attempting to suppress generic competition, a practice that significantly raises consumer drug prices. The Synthroid case settled in 2000 for an aggregate amount of $87.4 million.